Thermo Fisher Scientific Strengthens Anatomical Pathology Portfolio with Acquisition of Raymond A. Lamb
In business since 1964, Raymond A. Lamb has grown to become a global provider of products for the pathology laboratory. Recently, its focus has been on systems that automate the labeling and tracking of slides and cassettes that carry patient tissue samples, reducing the possibility of errors during their processing, storage and retrieval. The company has had a longstanding relationship with the anatomical pathology business of Thermo Fisher as a supplier of labeling products for cassettes and glass slides, as well as other anatomical pathology equipment.
"Our anatomical pathology customers - in both clinical and research markets - are demanding better solutions for tracking the increasing number of samples that they need to process and diagnose," said Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific. "This acquisition brings new-generation systems that can be integrated with our existing portfolio of anatomical pathology equipment and consumables to create a more efficient, and reliable, workflow."
Raymond A. Lamb had revenues of approximately $9 million in 2007, and will be integrated into Thermo Fisher's Analytical Technologies Segment.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.